5-MAPBT
| Clinical data | |
|---|---|
| Other names | MY400 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C12H15NS |
| Molar mass | 205.32 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5-MAPBT (5-methylaminopropylbenzothiophene) is an empathogenic drug of the benzothiophene group. It is closely related to 5-MAPB but with the oxygen atom replaced by sulfur, changing the core ring structure to benzothiophene rather than benzofuran.
It has been patented by Tactogen as an entactogen for potential use as a medicine.